Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Grifols ADR News

    4,00 € -2,91% -0,12 €
    08:05:48 Uhr Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1C3HH
    ISIN: US3984382008
    US-Symbol: GIKLY
    Typ: Aktie

    Grifols ADR News

    26.01.24 - PR Newswire
    ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF
    ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF ...
    18.01.24 - PR Newswire
    ROSEN, NATIONAL TRIAL LAWYERS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF
    ROSEN, NATIONAL TRIAL LAWYERS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF PR Newswire
    10.01.24 - PR Newswire
    ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF
    ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF PR Newswire
    03.11.22 - PR Newswire
    Grifols receives FDA clearance for AlphaID™ At Home, the first free service for U.S. consumers to determine their risk for alpha-1
    Grifols receives FDA clearance for AlphaID™ At Home, the first free service for U.S. consumers to determine their risk for alpha-1 PR Newswire
    03.10.22 - PR Newswire
    Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson
    Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson PR Newswire
    07.09.22 - PR Newswire
    Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada
    Grifols enters into agreement with Canadian Blood Services to accelerate self-​sufficiency in immunoglobulins for Canada PR Newswire
    07.09.22 - PR Newswire
    Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada
    Grifols enters into agreement with Canadian Blood Services to accelerate self-​sufficiency in immunoglobulins for Canada PR Newswire
    02.03.22 - PR Newswire
    Grifols partners with Feeding America® to help address hunger in the U.S.
    Grifols partners with Feeding America® to help address hunger in the U.S. - The Grifols Box Out Hunger food drive, in its first year as an official partner of Feeding America®, has a ...
    09.02.22 - PR Newswire
    Grifols PharmacyKeeper ranked No. 1 as 'Best in KLAS,' extends category leadership for sixth consecutive year
    Grifols PharmacyKeeper ranked No. 1 as 'Best in KLAS,' extends category leadership for sixth consecutive year - Renowned healthcare analyst firm KLAS Research continues to ...
    30.11.21 - PR Newswire
    Grifols reaches milestone with 300th U.S. plasma donor center, continuing to increase supply of urgently needed plasma
    Grifols reaches milestone with 300th U.S. plasma donor center, continuing to increase supply of urgently needed plasma - The new Biomat USA plasma donor center, located at ...
    04.11.21 - PR Newswire
    Grifols introduces ALBUTEIN FlexBag™ (Albumin [Human] U.S.P.) in 5% and 25% concentrations, a more convenient option for healthcare professionals
    Grifols introduces ALBUTEIN FlexBag™ (Albumin [Human] U.S.P.) in 5% and 25% concentrations, a more convenient option for healthcare professionals - The ALBUTEIN FlexBag, ...
    19.10.21 - PR Newswire
    Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicines
    Grifols and Egypt inaugurate first African plasma-​supply platform, in Cairo, as part of the alliance to attain self-​sufficiency in plasma-​derived medicines PR Newswire
    19.10.21 - PR Newswire
    Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicines
    Grifols and Egypt inaugurate first African plasma-​supply platform, in Cairo, as part of the alliance to attain self-​sufficiency in plasma-​derived medicines - This is the first time the ...
    01.06.21 - PR Newswire
    Grifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B
    Grifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B - The new formulation delivers anti-​hepatitis B ...
    19.05.21 - PR Newswire
    Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona
    Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona PR Newswire
    19.05.21 - PR Newswire
    Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona
    Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona PR Newswire
    28.04.21 - PR Newswire
    Grifols and Andorran government will establish world-class immunology research hub to expand global knowledge of the immune system and develop therapeutics
    Grifols and Andorran government will establish world-​class immunology research hub to expand global knowledge of the immune system and develop therapeutics PR Newswire
    15.04.21 - PR Newswire
    Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030
    Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030 - Grifols' new commitment of international units (IU) of blood clotting factors for ...
    02.04.21 - PR Newswire
    Grifols announces topline data from NIAID Phase 3 ITAC trial (INSIGHT-013) evaluating hyperimmune globulins as a treatment for hospitalized patients with COVID-19
    Grifols announces topline data from NIAID Phase 3 ITAC trial (INSIGHT-013) evaluating hyperimmune globulins as a treatment for hospitalized patients with COVID-19 Grifols ...
    25.03.21 - PR Newswire
    Grifols Procleix UltrioPlex E und Procleix Babesia Assays erhalten CE-Kennzeichnung
    Grifols Procleix UltrioPlex E und Procleix Babesia Assays erhalten CE-​Kennzeichnung PR Newswire

    Newssuche

    Videos

    newspaper
    09:30 Uhr +21,14%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »